SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANRG -- Anergen -- new CEO big chance ?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bob jaremsek who wrote (81)4/13/1998 5:14:00 PM
From: Marvin Frank  Read Replies (1) of 123
 
Has anyone read the 1997 Report for one of the most exciting reports on new product called DIAVAX. Preliminary animal tests showed that DIAVAX was able to act as a vaccine to prevent or delay the onset of type 1 diabetes in 75% of animals. This is a first for me and a great advance for any vaccine; even if only preliminary/ Too bad Anergen does not have enough funds to press forward on necessary research. Perhaps their partner will assist even more.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News